-       Report 
- June 2025
- Global 
   From       €4383EUR$4,900USD£3,855GBP 
          From       €6708EUR$7,500USD£5,901GBP 
            -       Report 
- August 2025
-  185 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  285 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
           -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Report 
- April 2025
-  150 Pages 
- Global 
   From       €3444EUR$3,850USD£3,029GBP 
      €4338EUR$4,850USD£3,816GBP 
          -       Report 
- July 2023
-  110 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- April 2023
-  80 Pages 
- United States 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- April 2023
-  80 Pages 
- United Kingdom 
   From       €1342EUR$1,500USD£1,180GBP 
          From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- April 2023
-  80 Pages 
- South Korea 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- April 2023
-  80 Pages 
- Saudi Arabia 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- April 2023
-  80 Pages 
- Russia 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- April 2023
-  80 Pages 
- Poland 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- April 2023
-  80 Pages 
- India 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- April 2023
-  80 Pages 
- Germany 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- April 2023
-  80 Pages 
- France 
   From       €1342EUR$1,500USD£1,180GBP 
          -       Report 
- April 2023
-  80 Pages 
- China 
   From       €1342EUR$1,500USD£1,180GBP 
            -       Report 
- April 2023
-  180 Pages 
- Global 
   From       €1118EUR$1,250USD£983GBP 
      €2236EUR$2,500USD£1,967GBP 
       
      Pertussis, also known as whooping cough, is a highly contagious respiratory infection caused by the bacterium Bordetella pertussis. It is a major cause of morbidity and mortality in children, particularly in developing countries. In pulmonary medicine, pertussis is treated with antibiotics, such as macrolides, and supportive care. Vaccination is the most effective way to prevent pertussis, and is recommended for all children and adults.
The pertussis market is a subset of the global pulmonary    medicine market, which is estimated to reach $50 billion by 2027. The pertussis market is driven by the increasing prevalence of the disease, the rising demand for vaccines, and the growing awareness of the importance of vaccination.
Some companies in the pertussis market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Johnson & Johnson. Show Less   Read more